Welcome to our dedicated page for Atlantic Coastal Acquisition Ii news (Ticker: ACABU), a resource for investors and traders seeking the latest updates and insights on Atlantic Coastal Acquisition Ii stock.
The ACABU news page on Stock Titan focuses on the history and corporate developments of Atlantic Coastal Acquisition Corp. II and its transition to Abpro Holdings, Inc. ACABU originally identified the units of a special purpose acquisition company listed on the Nasdaq Global Market. News coverage for this symbol centers on the SPAC’s capital markets activity, its initial public offering, and its later business combination with Abpro Corporation.
Investors reviewing ACABU-related news will find announcements about the upsized initial public offering of Atlantic Coastal Acquisition Corp. II units, including details on the number of units sold and the structure of the common stock and warrants. Subsequent news highlights the term sheet and definitive agreements for a business combination with Abpro Corporation, a biotechnology company focused on next-generation antibody therapies for severe and life-threatening diseases.
As the transaction progressed, news items described the implied equity valuation for Abpro, the intended use of proceeds to advance its drug pipeline toward clinical trials, and the expected impact on the combined company’s capital structure. Additional coverage includes the completion of the business combination, the renaming of the public entity to Abpro Holdings, Inc., and the listing of its common stock and warrants under the new Nasdaq symbols ABP and ABPWW.
Because ACABU is now primarily a historical trading symbol, the news archive is useful for understanding how Atlantic Coastal Acquisition Corp. II raised capital, identified a merger partner, and ultimately created Abpro Holdings, Inc. Readers can use this page to follow the sequence of corporate events from the SPAC’s IPO through the closing of the business combination and the establishment of the current biotechnology-focused public company.
Summary not available.
Atlantic Coastal Acquisition Corp. II announced that starting March 7, 2022, unit holders from their IPO can separately trade shares of Series A common stock and warrants. Whole warrants only will trade post-separation, with units trading on Nasdaq under symbol ACABU and separated stocks under symbols ACAB for common stock and ACABW for warrants. The offering was managed primarily by Cantor Fitzgerald & Co. and was registered with the SEC on January 13, 2022.
Atlantic Coastal Acquisition Corp. II (ACAH II) has successfully closed its upsized initial public offering (IPO) of 30 million units at $10.00 each, yielding gross proceeds of $300 million. This offering includes 3.9 million units from the underwriters' over-allotment option. The units, consisting of one share of Series A common stock and one-half warrant, are now listed on the Nasdaq under ticker symbol ACABU. The funds raised will be utilized for potential business combinations. The IPO's registration statement was effective as of January 13, 2022.